Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1986 Oct;83(20):7780–7784. doi: 10.1073/pnas.83.20.7780

Identification of a pituitary factor responsible for enhancement of plasminogen activator activity in breast tumor cells.

R Mira-y-Lopez, J Joseph-Silverstein, D B Rifkin, L Ossowski
PMCID: PMC386805  PMID: 3463998

Abstract

Sheep pituitary glands contain a protein that stimulates plasminogen activator (PA) activity 3- to 20-fold in serum-free cultures of T47D, MTW9/PL, and SC115 breast tumor cells. This protein was found to be similar to basic fibroblast growth factor (bFGF) in size, cationic nature, and affinity for heparin. Purified human placental bFGF, a homologue of human and bovine pituitary bFGF, was effective in stimulating mammary tumor cell PA at a concentration of 1 ng/ml. Antibodies to placental bFGF blocked the PA stimulatory activity of sheep pituitary extracts. Because of these properties, the active protein in sheep pituitary glands was identified as bFGF. This represents another function of bFGF, indicating that its spectrum of target cells is wider than previously thought. Because of previously established correlations between PA production in vitro and tumor growth in vivo, we suggest that bFGF may contribute to the growth of breast carcinomas in vivo. Other types of carcinomas may also be affected by bFGF.

Full text

PDF
7780

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baird A., Böhlen P., Ling N., Guillemin R. Radioimmunoassay for fibroblast growth factor (FGF): release by the bovine anterior pituitary in vitro. Regul Pept. 1985 Apr;10(4):309–317. doi: 10.1016/0167-0115(85)90043-6. [DOI] [PubMed] [Google Scholar]
  2. Baird A., Mormède P., Ying S. Y., Wehrenberg W. B., Ueno N., Ling N., Guillemin R. A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion. Proc Natl Acad Sci U S A. 1985 Aug;82(16):5545–5549. doi: 10.1073/pnas.82.16.5545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  4. Butler W. B., Kirkland W. L., Gargala T. L., Goran N., Kelsey W. H., Berlinski P. J. Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7). Cancer Res. 1983 Apr;43(4):1637–1641. [PubMed] [Google Scholar]
  5. Böhlen P., Baird A., Esch F., Ling N., Gospodarowicz D. Isolation and partial molecular characterization of pituitary fibroblast growth factor. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5364–5368. doi: 10.1073/pnas.81.17.5364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dembinski T. C., Leung C. K., Shiu R. P. Evidence for a novel pituitary factor that potentiates the mitogenic effect of estrogen in human breast cancer cells. Cancer Res. 1985 Jul;45(7):3083–3089. [PubMed] [Google Scholar]
  7. Dickson R. B., McManaway M. E., Lippman M. E. Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science. 1986 Jun 20;232(4757):1540–1543. doi: 10.1126/science.3715461. [DOI] [PubMed] [Google Scholar]
  8. Engelsman E., Heuson J. C., Blonk Van Der Wijst J., Drochmans A., Maass H., Cheix F., Sobrinho L. G., Nowakowski H. Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer: an E.O.R.T.C. study. Br Med J. 1975 Jun 28;2(5973):714–715. doi: 10.1136/bmj.2.5973.714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Esch F., Baird A., Ling N., Ueno N., Hill F., Denoroy L., Klepper R., Gospodarowicz D., Böhlen P., Guillemin R. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6507–6511. doi: 10.1073/pnas.82.19.6507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fairney A., Morgan L., Barrett A., de Souza I., Barnes G. Anterior pituitary function following hypophysectomy for breast cancer. Clin Oncol. 1976 Jun;2(2):121–126. [PubMed] [Google Scholar]
  11. Gospodarowicz D., Cheng J., Lui G. M., Baird A., Böhlent P. Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor. Proc Natl Acad Sci U S A. 1984 Nov;81(22):6963–6967. doi: 10.1073/pnas.81.22.6963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gospodarowicz D. Purification of a fibroblast growth factor from bovine pituitary. J Biol Chem. 1975 Apr 10;250(7):2515–2520. [PubMed] [Google Scholar]
  13. Hammond S. L., Ham R. G., Stampfer M. R. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Natl Acad Sci U S A. 1984 Sep;81(17):5435–5439. doi: 10.1073/pnas.81.17.5435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ikeda T., Danielpour D., Sirbasku D. A. Characterization of a sheep pituitary-derived growth factor for rat and human mammary tumor cells. J Cell Biochem. 1984;25(4):213–229. doi: 10.1002/jcb.240250404. [DOI] [PubMed] [Google Scholar]
  15. Laug W. E., DeClerck Y. A., Jones P. A. Degradation of the subendothelial matrix by tumor cells. Cancer Res. 1983 Apr;43(4):1827–1834. [PubMed] [Google Scholar]
  16. Leung C. K., Shiu R. P. Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice. Cancer Res. 1981 Feb;41(2):546–551. [PubMed] [Google Scholar]
  17. Mak T. W., Rutledge G., Sutherland D. J. Androgen-dependent fibrinolytic activity in a murine mammary carcinoma (Shionogi SC-115 cells) in vitro. Cell. 1976 Feb;7(2):223–226. doi: 10.1016/0092-8674(76)90021-0. [DOI] [PubMed] [Google Scholar]
  18. McManus M. J., Welsch C. W. Hormone-induced ductal DNA synthesis of human breast tissues maintained in the athymic nude mouse. Cancer Res. 1981 Sep;41(9 Pt 1):3300–3305. [PubMed] [Google Scholar]
  19. Mira-y-Lopez R., Reich E., Ossowski L. Modulation of plasminogen activator in rodent mammary tumors by hormones and other effectors. Cancer Res. 1983 Nov;43(11):5467–5477. [PubMed] [Google Scholar]
  20. Mira-y-Lopez R., Reich E., Stolfi R. L., Martin D. S., Ossowski L. Coordinate inhibition of plasminogen activator and tumor growth by hydrocortisone in mouse mammary carcinoma. Cancer Res. 1985 May;45(5):2270–2276. [PubMed] [Google Scholar]
  21. Moscatelli D., Presta M., Rifkin D. B. Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. Proc Natl Acad Sci U S A. 1986 Apr;83(7):2091–2095. doi: 10.1073/pnas.83.7.2091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ossowski L., Reich E. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell. 1983 Dec;35(3 Pt 2):611–619. doi: 10.1016/0092-8674(83)90093-4. [DOI] [PubMed] [Google Scholar]
  23. PEARSON O. H., RAY B. S. Hypophysectomy in the treatment of metastatic mammary cancer. Am J Surg. 1960 Apr;99:544–552. doi: 10.1016/0002-9610(60)90149-5. [DOI] [PubMed] [Google Scholar]
  24. Paranjpe M., Engel L., Young N., Liotta L. A. Activation of human breast carcinoma collagenase through plasminogen activator. Life Sci. 1980 Apr 14;26(15):1223–1231. doi: 10.1016/0024-3205(80)90067-3. [DOI] [PubMed] [Google Scholar]
  25. Pearson O. H., Manni A., Chambers M., Brodkey J., Marshall J. S. Role of pituitary hormones in the growth of human breast cancer. Cancer Res. 1978 Nov;38(11 Pt 2):4323–4326. [PubMed] [Google Scholar]
  26. Rowe J. M., Kasper S., Shiu R. P., Friesen H. G. Purification and characterization of a human mammary tumor-derived growth factor. Cancer Res. 1986 Mar;46(3):1408–1412. [PubMed] [Google Scholar]
  27. Shafie S. M. Estrogen and the growth of breast cancer: new evidence suggests indirect action. Science. 1980 Aug 8;209(4457):701–702. doi: 10.1126/science.6994231. [DOI] [PubMed] [Google Scholar]
  28. Strickland S., Beers W. H. Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins. J Biol Chem. 1976 Sep 25;251(18):5694–5702. [PubMed] [Google Scholar]
  29. Strickland S., Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell. 1978 Oct;15(2):393–403. doi: 10.1016/0092-8674(78)90008-9. [DOI] [PubMed] [Google Scholar]
  30. Welsch C. W., Swim E. L., McManus M. J., White A. C., McGrath C. M. Estrogen induced growth of human breast cancer cells (MCF-7) in athymic nude mice is enhanced by secretions from a transplantable pituitary tumor. Cancer Lett. 1981 Dec;14(3):309–316. doi: 10.1016/0304-3835(81)90160-9. [DOI] [PubMed] [Google Scholar]
  31. Yamashita J., Horiuchi S., Shigaki N., Fujino N., Akagi M. Estrogen-dependent plasminogen activator in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors in vivo and in vitro. Gan. 1984 Aug;75(8):681–689. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES